Skip to main content

Table 2 Comparison between asthmatics and control regarding demographic and laboratory data

From: Vitamin D and cathelicidin assessment in infection-induced asthma in Egyptian children

Variable

Healthy control

(group 1)

Patients in remission

(group 2)

Patients in excerption

(group 3)

p value

(between groups)

Age

8.8 ± 2.2

9.3 ± 2.4

9.2 ± 2.3

0.7

Sex males/females

15/20

19/13

21/11

0.8

Weight (kg)

31.2 ± 11.1

30.6 ± 9.6

31.9 ± 12.7

0.9

Height (cm)

130.7 ± 11.2

125.7 ± 9.8

129.2 ± 9.7

0.2

BMI (kg/m2)

17.7 ± 3.4

19.2 ± 5

18.5 ± 4.9

0.5

HB (gm/dl)

12.9 ± 1.6

12.7 ± 1.02

12.6 ± 0.9

0.9

RBCs (cells/mm3)

4.70

4.76

4.73

0.63

WBCs (cells/mm3)

5.8 ± 1.5

7.5 ± 2.5*

(p = 0.03)

8.9 ± 4.2**

(p = 0.001)

0.001

AEC (cells/mm3)

207.8 ± 119.1

340.1 ± 312.3

389.7 ± 347**

(p = 0.01)

0.04

Vitamin D (ng/ml)

10.77 ± 5.6

9.8 ± 4.89

8.49 ± 5

0.29

Serum cathelicidin (ng/ml)

7.69 ± 4.3

6.88 ± 3.66

9.78 ± 3.03***

(p = 0.01)

0.03

  1. BMI body mass index, AEC absolute eosinophilic count
  2. *Comparing healthy controls with patients in remission (groups 1 and 2)
  3. **Comparing healthy controls with patients in exacerbation (groups 1 and 3)
  4. ***Comparing patients in remission with patients in exacerbation (groups 2 and 3)